drugset / Trial / NCT03868436
PENTHROX™ in the Canadian Emergency Department (ED)
NaSingle-groupOpen-labelTreatment
Summary
This Canadian, multi-centre, prospective, real world study is designed to evaluate the effectiveness of low dose methoxyflurane (MEOF) (PENTHROX™) for the treatment of moderate to severe pain associated with trauma in the Canadian ED.
Timeline
- Start
- 2019-04-08
- Primary completion
- 2020-03-30
- Completion
- 2020-09-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methoxyflurane | Small molecule | 3 ml | Inhaled |
Indications
No indication recorded.